Dashboard
Manage Tickers

ANIP


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ani-pharmaceuticals-launches-promethazine-hydrochloride-and-dextromethorphan-hydrobromide-oral-solution
Ani Pharmaceuticals Launches Promethazine ...
09/13/2024 10:51:22

this-novartis-analyst-is-no-longer-bullish-here-are-top-downgrades-for-wednesday
This Novartis Analyst Is No Longer Bullish...
09/11/2024 16:13:54

Core News & Articles
ANI Pharmaceuticals And Alimera Sciences A...
09/11/2024 10:56:40

truist-securities-downgrades-ani-pharmaceuticals-to-hold-lowers-price-target-to-60
Truist Securities Downgrades ANI Pharmaceu...
09/11/2024 10:47:37

Truist Securities analyst Gregory Fraser downgrades ANI Pharmaceuticals (NASDAQ:ANIP) from Buy to Hold and lowers the price ...

ani-pharmaceuticals-updates-on-alimera-sciences-acquisition-states-discussions-regarding-closing-conditions-are-ongoing-but-expected-to-be-resolved-promptly
ANI Pharmaceuticals Updates On Alimera Sci...
09/10/2024 18:15:37

Core News & Articles
Alimera Sciences Takes Legal Action Agains...
09/10/2024 13:02:42

Alimera Has Filed Lawsuit in the Delaware Court of Chancery to Compel ANI to Close Merger Transaction and Honor its Contractual...

hc-wainwright--co-reiterates-buy-on-ani-pharmaceuticals-maintains-94-price-target
HC Wainwright & Co. Reiterates Buy on ANI ...
08/07/2024 12:19:31

HC Wainwright & Co. analyst Oren Livnat reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $94 price ...

ani-pharmaceuticals-announced-its-intention-to-offer-subject-to-market-and-other-conditions-250000000-aggregate-principal-amount-of-convertible-senior-notes-due-2029-in-a-private-offering
ANI Pharmaceuticals Announced Its Intentio...
08/07/2024 11:14:44

ani-pharmaceuticals-forecasts-2024-adjusted-eps-of-438-482-versus-prior-guidance-of-426-467-and-consensus-of-449
ANI Pharmaceuticals Forecasts 2024 Adjuste...
08/06/2024 11:03:05

Revised Full Year 2024 Guidance:The following guidance for 2024 does not include contribution from the pending acquisition of A...

ani-pharmaceuticals-forecasts-2024-net-revenue-of-540m-560m-versus-prior-guidance-of-520m-542m-and-consensus-of-554598m-with-cortrophin-gel-revenue-of-185m-195m-compared-to-prior-guidance-of-170m-180m
ANI Pharmaceuticals Forecasts 2024 Net Rev...
08/06/2024 11:01:15

ani-pharmaceuticals-q2-2024-adj-eps-102-beats-095-estimate-sales-138040m-beat-129054m-estimate
ANI Pharmaceuticals Q2 2024 Adj. EPS $1.02...
08/06/2024 10:51:30

anis-generic-l-glutamine-oral-powder-hits-market-targets-201m-annual-sales
ANI's Generic L-Glutamine Oral Powder Hits...
07/15/2024 11:05:00

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that following final approval from the U.S. Food a...

ani-pharmaceuticals-announces-fda-approval-and-launch-of-its-naproxen-delayed-release-tablets-usp
ANI Pharmaceuticals Announces FDA Approval...
07/02/2024 11:03:31

Core News & Articles
NVIDIA To Rally Around 19%? Here Are 10 To...
06/26/2024 12:12:59

hc-wainwright--co-maintains-buy-on-ani-pharmaceuticals-raises-price-target-to-94
HC Wainwright & Co. Maintains Buy on ANI P...
06/26/2024 10:43:52

HC Wainwright & Co. analyst Oren Livnat maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price targ...

nasdaq-records-worst-session-since-april-with-nvidia-plunging-7-dow-jones-sees-modest-gains-amid-mixed-market-close
Nasdaq Records Worst Session Since April W...
06/25/2024 06:45:26

generics-player-ani-pharmaceuticals-strengthens-rare-disease-segment-with-380m-alimera-sciences-deal
Generics Player ANI Pharmaceuticals Streng...
06/24/2024 15:28:28

ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per s...

Core News & Articles
ANI Pharma to Snap Alimera Sciences Valuin...
06/24/2024 10:55:27

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) ("ANI" or the "Company") and Alimera Sciences, Inc. (NASDAQ:ALIM) ("...

ani-pharmaceuticals-has-launched-kionex-sodium-polystyrene-sulfonate-suspension-usp-for-oral-or-rectal-use
ANI Pharmaceuticals Has Launched Kionex (S...
05/20/2024 10:52:47

U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2...

hc-wainwright--co-maintains-buy-on-ani-pharmaceuticals-raises-price-target-to-87
HC Wainwright & Co. Maintains Buy on ANI P...
05/13/2024 15:03:46

HC Wainwright & Co. analyst Oren Livnat maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price targ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION